Skip to main content

CERENOME, INC.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

CNSY$0.57-11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

EXHIBIT INDEX

Exhibit NumberExhibit TitleFiled with this Form 10-QIncorporated by Reference
FormFile No.Date Filed
3.1Composite Certificate of Incorporation10-K001-34375 Exhibit 3.103/11/2016
3.2Certificate of Amendment to Amended and Restated Certificate8-K001-34375 Exhibit 3.105/10/2016
3.3Certificate of Amendment to Amended and Restated Certificate8-K001-34375 Exhibit 3.105/23/2018
3.4Certificate of Amendment to Amended and Restated Certificate8-K001-34375 Exhibit 3.107/29/2019
3.5Certificate of Amendment to Amended and Restated Certificate8-K001-34375 Exhibit 3.108/06/2019
3.6Certificate of Amendment to Amended and Restated Certificate8-K001-34375 Exhibit 3.104/28/2023
3.7Certificate of Amendment to the Certificate of Incorporation, as amended8-K001-34375 Exhibit 3.105/02/2025
3.8Certificate of Amendment to the Amended and Restated Certificate of Incorporation, filed with the Delaware Secretary of State on April 1, 20268-K001-34375 Exhibit 3.104/02/2026
3.9Certificate of Correction to the Amended and Restated Certificate of Incorporation, filed with the Delaware Secretary of State on May 12, 202610-Q001-34375 Exhibit 3.905/15/2026
3.10Certificate of Amendment to Amended and Restated Certificate of Incorporation, filed with the Delaware Secretary of State effective August 3, 20268-K001-34375 Exhibit 3.108/04/2026
3.11Second Amended and Restated Bylaws of Cerenome, Inc.8-K001-34375 Exhibit 3.208/04/2026
3.12Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock8-K001-34375Exhibit 3.111/28/2017
3.13Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock8-K001-34375Exhibit 3.107/25/2018
3.142020 Stock Incentive Plan, as amended and restated on May 14, 202610-Q001-34375Exhibit 3.1305/15/2026
4.1Description of Securities10-K001-34375Exhibit 4.103/30/2020
4.2Form of Common Stock Certificate10-K001-34375Exhibit 4.3303/09/2018
4.3Form of May 2024 Pre-Funded Warrant8-K001-34375Exhibit 4.105/09/2024
4.4Form of Amendment and Restatement of the May 2024 Series A Warrant10-Q011-34375Exhibit 4.708/14/2024
4.5Form of Amendment and Restatement of the May 2024 Series B Warrant10-Q011-34375Exhibit 4.808/14/2024
4.6Form of February 2025 Pre-Funded Warrant8-K011-34375Exhibit 4.102/18/2025
4.7Form of Warrant issued pursuant to the Securities Purchase and Exchange Agreement, dated February 13, 2025, by and among Cerenome, Inc. and the purchasers named therein8-K001-34375Exhibit 4.202/18/2025
4.8Form of March 2025 Pre-Funded Warrant8-K001-34375Exhibit 4.103/04/2025
4.9Form of Amended March 2025 Series B Warrant8-K001-34375Exhibit 4.106/17/2025
4.10Form of Warrant, dated January 15, 20268-K001-34375Exhibit 4.101/16/2026
10.1Daniels Employment Agreement, effective April 20, 2026X
10.2Equity Distribution Agreement, by and between the Company and Canaccord Genuity LLC, dated as of June 1, 20268-K001-34375Exhibit 1.106/05/2026
10.3†First Amendment to Lease, by and between LG 1 Property Owner LP and Cerenome, Inc., dated as of August 10, 2026X
31.1Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-1.04(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
31.2Certification of Principal Financial and Accounting Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
32.1*Certifications Pursuant to 18 U.S.C. Section 1350/ Securities Exchange Act Rule 13a-14(b), as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002X
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbase DocumentsX
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)X
  • In accordance with Item 601(b)(32)(ii) of Regulation S‑K and SEC Release No. 34‑47986, the certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Form 10‑Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933 except to the extent that the Company specifically incorporates them by reference.

† Portions of this document have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CERENOME, INC.
By:/s/ Marc H. Hedrick
Dated: August 14, 2026Marc H. Hedrick
President & Chief Executive Officer (Duly Authorized Officer and Principal Executive Officer)
By:/s/ Andrew Sims
Dated: August 14, 2026Andrew Sims
Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer and Principal Accounting Officer)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.